| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.33 | 0.09 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |